SCHEMBL7112340

SCHEMBL7112340

CN(C)c1ccccc1Nc1nc(Nc2ccc(C(=O)O)cc2)c2nc[nH]c2n1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 5/20 0.45
TOP2A P11388 1/20 0.43
BRAF P15056 1/20 0.43
AURKA O14965 10/20 0.43
GSK3A P49840 4/20 0.43
JAK2 O60674 1/20 0.40
AURKB Q96GD4 1/20 0.40
PIN1 Q13526 1/20 0.40
CHEK1 O14757 1/20 0.39
NTRK2 Q16620 1/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4D Q08499 1/20 0.39
PTK2 Q05397 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4892709 0.87 RAB9A (0.50) AURKAMEN1MAPTKMT2A
SCHEMBL7112335 0.84 GSK3B (0.46) GSK3BTOP2ABRAFAURKAGSK3A
SCHEMBL7108322 0.76 GSK3B (0.50) GSK3BTOP2ABRAFAURKAGSK3A
SCHEMBL7107687 0.76 ALK (0.57) AURKACHEK1NTRK2MEN1MAPT
SCHEMBL459413 0.74 IGF1R (0.51) GSK3BAURKAGSK3AJAK2AURKB
SCHEMBL7110570 0.73 POLB (0.55) GSK3BTOP2ABRAFAURKAGSK3A
SCHEMBL7106217 0.73 GSK3B (0.53) GSK3BAURKAGSK3APIN1MEN1
SCHEMBL7106210 0.73 GSK3B (0.53) GSK3BAURKAGSK3APIN1MEN1
SCHEMBL7104854 0.72 SMN1; SMN2 (0.56) BRAFMEN1MAPTKMT2A
SCHEMBL7105790 0.72 MERTK (0.53) GSK3BTOP2ABRAFPIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1347975-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES Aventis Pharma S.A. (FR) 2003-10-01 EP claimed
WO-2002051843-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES AVENTIS PHARMA S.A. (FR) 2002-07-04 WO claimed
EP-1347975-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES Aventis Pharma S.A. (FR) 2003-10-01 EP disclosed
WO-2002051843-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES AVENTIS PHARMA S.A. (FR) 2002-07-04 WO disclosed